Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

NCT00729612 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: paclitaxel albumin-stabilized nanoparticle formulation
GENETIC: protein expression analysis
OTHER: immunoenzyme technique
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis

Sponsor

Greg Otterson

Collaborators

[object Object]
[object Object]